Cargando…
Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care
BACKGROUND AND OBJECTIVE: Aegis Sciences Corporation developed a test (InterACT Rx(™)) that objectively and definitively identifies substances known to interact with drug–drug interaction-prone medications commonly prescribed in the treatment of chronic pain and behavioral health disorders. The obje...
Autores principales: | Arnold, Renée J. G., Tang, Jun, Schrecker, Joshua, Hild, Cheryl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265235/ https://www.ncbi.nlm.nih.gov/pubmed/30298445 http://dx.doi.org/10.1007/s40801-018-0143-z |
Ejemplares similares
-
Clinical Utility of Definitive Drug–Drug Interaction Testing in Primary Care
por: Peabody, John, et al.
Publicado: (2018) -
Drug-Drug Interaction Assessment and Identification in the Primary Care Setting
por: Peabody, John, et al.
Publicado: (2018) -
Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
por: Peabody, John, et al.
Publicado: (2021) -
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
por: Peabody, John W, et al.
Publicado: (2023) -
Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug–Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians
por: Valdenor, Czarlota, et al.
Publicado: (2022)